S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
This NASDAQ Stock Is The Amazon Of Medical Supply (Ad)
Stock market today: Asian stocks rise after Wall St retreats on concern economy weakening
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
LON:SCLP

Scancell (SCLP) Share Forecast, Price & News

GBX 15.50
0.00 (0.00%)
(As of 06/5/2023 ET)
Compare
Today's Range
15.37
15.66
50-Day Range
14.25
20.50
52-Week Range
10.75
29.40
Volume
199,193 shs
Average Volume
761,369 shs
Market Capitalization
£126.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SCLP stock logo

About Scancell (LON:SCLP) Stock

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, an ImmunoBody cancer vaccine for the treatment of metastatic melanoma; SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumours, including non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.

Receive SCLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scancell and its competitors with MarketBeat's FREE daily newsletter.

SCLP Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Lithium Has Boomed And This American Stock Is Ready..
Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!
Scancell hails period of clinical and commercial progress
Scancell Holdings plc (SCLP.L)
Why is the Scancell share price climbing?
Scancell executive chairman John Chiplin to step down
Scancell says executive chairman John Chiplin to step down
NAV Update - StreetInsider.com
See More Headlines

SCLP Price History

SCLP Company Calendar

Last Earnings
1/31/2020
Today
6/05/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
25
Year Founded
N/A

Profitability

Net Income
£-8,440,000.00
Net Margins
-160.08%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£5.27 million
Cash Flow
GBX 1.97 per share
Book Value
GBX 2 per share

Miscellaneous

Free Float
N/A
Market Cap
£126.85 million
Optionable
Not Optionable
Beta
0.59

Key Executives

  • Prof. Lindy Gillian Durrant Ph.D.
    Founder, CEO, Chief Scientific Officer & Director
  • Dr. Sally Elizabeth Adams (Age 61)
    Chief Devel. Officer & Director
    Comp: $255.65k
  • Mr. Keith Green
    Director of Fin. & Admin. and Company Sec.
  • Dr. Samantha Paston Ph.D.
    Head of Translational Research
  • Dr. Adrian Parry Ph.D.
    Head of Manufacturing
  • Ms. Akua Asare
    Head of Quality
  • Mr. Fayaz Master
    Head of Clinical Operations













SCLP Stock - Frequently Asked Questions

How have SCLP shares performed in 2023?

Scancell's stock was trading at GBX 24.75 at the beginning of the year. Since then, SCLP shares have decreased by 37.4% and is now trading at GBX 15.50.
View the best growth stocks for 2023 here
.

How were Scancell's earnings last quarter?

Scancell Holdings plc (LON:SCLP) released its quarterly earnings data on Friday, January, 31st. The company reported ($0.56) EPS for the quarter. Scancell had a negative net margin of 160.08% and a negative trailing twelve-month return on equity of 44.27%.

What other stocks do shareholders of Scancell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Scancell investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Petropavlovsk (POG), AorTech International (AOR), Ascential (ASCL), Advanced Oncotherapy (AVO), Empyrean Energy (EME), Lloyds Banking Group (LYG), Aminex (AEX) and Sound Energy (SOU).

What is Scancell's stock symbol?

Scancell trades on the London Stock Exchange (LON) under the ticker symbol "SCLP."

How do I buy shares of Scancell?

Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Scancell's stock price today?

One share of SCLP stock can currently be purchased for approximately GBX 15.50.

How much money does Scancell make?

Scancell (LON:SCLP) has a market capitalization of £126.85 million and generates £5.27 million in revenue each year. The company earns £-8,440,000.00 in net income (profit) each year or GBX (0.01) on an earnings per share basis.

How can I contact Scancell?

Scancell's mailing address is Department of Clinical Oncology Hucknall Road, NOTTINGHAM, NG5 1PB, United Kingdom. The official website for the company is www.scancell.co.uk. The company can be reached via phone at +44-115-8231863.

This page (LON:SCLP) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -